Basu, Anirban; Meltzer, David - In: PharmacoEconomics 30 (2012) 10, pp. 859-868
The recent rush of enthusiasm for public investment in comparative effectiveness research (CER) in the US has focussed attention on these public investments. However, little attention has been given to how changing public investment in CER may affect private manufacturers’ incentives for CER,...